Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Scrip Awards
Partnered Content
Scrip Asia 100
Report Store
Ask The Analyst
PItCH
PDF Library
RSS Feeds
Subscribe
Advertise
UsernamePublicRestriction
Tags:
India Legal Issues Commercial

Novartis Ceritinib India Case: Court Rebuke Amid Wait For Patent Decision

  • Analysis

Executive Summary

An Indian court has frowned upon Novartis and opponent Natco for seemingly delaying proceedings before the Controller General of Patents in a case concerning the Swiss firm’s anticancer ceritinib. The patent office wasn’t spared either, with the court asking the Controller to ensure that once orders are reserved, a time period is prescribed for delivering the decision.

You may also be interested in...



Shadow On Novartis' Ceritinib In India After Patent Is Revoked

A patent on Novartis’ ceritinib has been rescinded in India, giving challenger Natco the upper hand, though the Swiss multinational has filed an appeal and hopes to have the patent reinstated.

Shadow On Novartis' Ceritinib In India After Patent Revoked

A patent on Novartis’ceritinib has been rescinded in India, giving challenger Natco the upper hand, though the Swiss multinational has filed an appeal and hopes to have the patent reinstated.

Chiesi Files India Legal Action Against Cipla Over Respiratory Therapy Patent

The Italian firm has initiated legal proceedings in India against Cipla, alleging infringement of a patent for an inhalation therapy.
Table

View full table

Topics

Related Companies

Tags:
India Legal Issues Commercial
UsernamePublicRestriction

Register

SC125578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By